Head to head
LiveRamp vs Microsoft
Side-by-side on the measures that matter, with a plain-English read. Full detail: RAMP · MSFT
RAMP
LiveRamp
38.50+0.00%
1-year price shape — +41% over the period
Quant Rating C · 80/100
vs
MSFT
Microsoft
484.52-2.77%
1-year price shape — +2% over the period
Quant Rating C · 40/100
1-year performance, rebased to 100
Microsoft edges it on the scoreable measures. Microsoft pays the highest dividend yield; Microsoft earns the most per share.
| RAMP | MSFT | |
|---|---|---|
| Snapshot | ||
| Sector | Software - Infrastructure | Software - Infrastructure |
| Last price | 38.50 | 484.52 |
| Change today | +0.00% | -2.77% |
| 1-year return | +40.9% | +1.9% |
| Market cap | $2.35B | $3.60T |
| 52-week range | 21.71 – 38.52 | 347.87 – 558.07 |
| Valuation | ||
| P/E (TTM) | 16.74 | 25.30 |
| P/E percentile, own 5-yr range | 67th | 21st |
| P/B | 2.32 | 7.65 |
| Dividend yield | 0.00% | 0.75% |
| Profitability & growth | ||
| EPS (TTM) | 2.24 | 17.95 |
| Net profit (TTM) | $136.67M | $133.30B |
| Revenue (TTM) | $832.10M | $346.45B |
| Provider revenue period date | 2026-06-29 | 2026-09-29 |
| Revenue growth (YoY) | +9.8% | +18.8% |
| Gross margin | 70.8% | 67.7% |
| Operating margin | 12.9% | 47.1% |
| Net margin | 18.7% | 41.2% |
| Free cash flow (TTM) | $200.03M | $59.96B |
| Provider cash-flow period date | 2026-06-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 96.5% | 75.7% |
| Insider activity (12mo) | 26 buy / 23 sell | 30 buy / 17 sell |
| Short interest (% of float) | 10.7% | 0.8% |
| Analyst consensus | 100% hold (2) | 94% buy / 6% hold (36) |
| Analyst price target | $39 (+0%) | $642 (+32%) |
| StockVane view | ||
| StockVane Quant Rating | C (80) | C (40) |
| Company | ||
| Employees | 1,300 | 223,000 |
| Founded | 1969 | 1975 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.